131 related articles for article (PubMed ID: 7556953)
1. Role of phosphodiesterase III in the antilipolytic effect of insulin in vivo.
Hagström-Toft E; Bolinder J; Eriksson S; Arner P
Diabetes; 1995 Oct; 44(10):1170-5. PubMed ID: 7556953
[TBL] [Abstract][Full Text] [Related]
2. Various phosphodiesterase subtypes mediate the in vivo antilipolytic effect of insulin on adipose tissue and skeletal muscle in man.
Enoksson S; Degerman E; Hagström-Toft E; Large V; Arner P
Diabetologia; 1998 May; 41(5):560-8. PubMed ID: 9628274
[TBL] [Abstract][Full Text] [Related]
3. Importance of phosphodiesterase 3 for the lipolytic response in adipose tissue during insulin-induced hypoglycemia in normal man.
Moberg E; Enoksson S; Hagström-Toft E
Horm Metab Res; 1998 Nov; 30(11):684-8. PubMed ID: 9918386
[TBL] [Abstract][Full Text] [Related]
4. In situ regulation of lipolysis by insulin and norepinephrine: a microdialysis study during euglycemic-hyperinsulinemic clamp.
Cimmino M; Agosto A; Minaire Y; Géloën A
Metabolism; 1995 Dec; 44(12):1513-8. PubMed ID: 8786716
[TBL] [Abstract][Full Text] [Related]
5. Milrinone, a selective phosphodiesterase 3 inhibitor, stimulates lipolysis, endogenous glucose production, and insulin secretion.
Cheung P; Yang G; Boden G
Metabolism; 2003 Nov; 52(11):1496-500. PubMed ID: 14624413
[TBL] [Abstract][Full Text] [Related]
6. Effect of phosphodiesterase inhibition with amrinone or theophylline on lipolysis and blood flow in human adipose tissue in vivo as measured with microdialysis.
Arner P; Hellmér J; Hagström-Toft E; Bolinder J
J Lipid Res; 1993 Oct; 34(10):1737-43. PubMed ID: 8245724
[TBL] [Abstract][Full Text] [Related]
7. Studies of phosphodiesterase effects on adipose tissue metabolism in obese subjects by the microdialysis technique.
Flechtner-Mors M; Jenkinson CP; Alt A; Biesalski HK; Adler G; Ditschuneit HH
J Physiol Pharmacol; 2005 Sep; 56(3):355-68. PubMed ID: 16204759
[TBL] [Abstract][Full Text] [Related]
8. Ginseng extract inhibits lipolysis in rat adipocytes in vitro by activating phosphodiesterase 4.
Wang H; Reaves LA; Edens NK
J Nutr; 2006 Feb; 136(2):337-42. PubMed ID: 16424109
[TBL] [Abstract][Full Text] [Related]
9. Regulation and counterregulation of lipolysis in vivo: different roles of sympathetic activation and insulin.
Navegantes LC; Sjöstrand M; Gudbjörnsdottir S; Strindberg L; Elam M; Lönnroth P
J Clin Endocrinol Metab; 2003 Nov; 88(11):5515-20. PubMed ID: 14602799
[TBL] [Abstract][Full Text] [Related]
10. Effect of insulin on human adipose tissue metabolism in situ. Interactions with beta-adrenoceptors.
Hagström-Toft E; Arner P; Johansson U; Eriksson LS; Ungerstedt U; Bolinder J
Diabetologia; 1992 Jul; 35(7):664-70. PubMed ID: 1322851
[TBL] [Abstract][Full Text] [Related]
11. Effects of 10 days of endurance exercise training on the suppression of whole body and regional lipolysis by insulin.
Hickner RC; Racette SB; Binder EF; Fisher JS; Kohrt WM
J Clin Endocrinol Metab; 2000 Apr; 85(4):1498-504. PubMed ID: 10770188
[TBL] [Abstract][Full Text] [Related]
12. Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in humans.
Stumvoll M; Jacob S; Wahl HG; Hauer B; Löblein K; Grauer P; Becker R; Nielsen M; Renn W; Häring H
J Clin Endocrinol Metab; 2000 Oct; 85(10):3740-5. PubMed ID: 11061533
[TBL] [Abstract][Full Text] [Related]
13. Activation of alpha2-adrenergic receptors blunts epinephrine-induced lipolysis in subcutaneous adipose tissue during a hyperinsulinemic euglycemic clamp in men.
Stich V; Pelikanova T; Wohl P; Sengenès C; Zakaroff-Girard A; Lafontan M; Berlan M
Am J Physiol Endocrinol Metab; 2003 Sep; 285(3):E599-607. PubMed ID: 12900381
[TBL] [Abstract][Full Text] [Related]
14. Suppression of whole body and regional lipolysis by insulin: effects of obesity and exercise.
Hickner RC; Racette SB; Binder EF; Fisher JS; Kohrt WM
J Clin Endocrinol Metab; 1999 Nov; 84(11):3886-95. PubMed ID: 10566624
[TBL] [Abstract][Full Text] [Related]
15. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
Eckly AE; Lugnier C
Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
[TBL] [Abstract][Full Text] [Related]
16. Effects of different phosphodiesterase inhibitors on the antilipolytic action of insulin in human adipocytes.
Kather H; Scheurer A
Horm Metab Res; 1987 Aug; 19(8):379-81. PubMed ID: 2822563
[TBL] [Abstract][Full Text] [Related]
17. Action of glucagon and glucagon-like peptide-1-(7-36) amide on lipolysis in human subcutaneous adipose tissue and skeletal muscle in vivo.
Bertin E; Arner P; Bolinder J; Hagström-Toft E
J Clin Endocrinol Metab; 2001 Mar; 86(3):1229-34. PubMed ID: 11238513
[TBL] [Abstract][Full Text] [Related]
18. Acute peripheral tissue effects of ghrelin on interstitial levels of glucose, glycerol, and lactate: a microdialysis study in healthy human subjects.
Vestergaard ET; Møller N; Jørgensen JO
Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1273-80. PubMed ID: 23592479
[TBL] [Abstract][Full Text] [Related]
19. Regional difference in lipolysis caused by a beta-adrenergic agonist as determined by the microdialysis technique.
Iwao N; Oshida Y; Sato Y
Acta Physiol Scand; 1997 Dec; 161(4):481-7. PubMed ID: 9429655
[TBL] [Abstract][Full Text] [Related]
20. No effect of the Trp64Arg beta 3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue.
Snitker S; Odeleye OE; Hellmér J; Boschmann M; Monroe MB; Shuldiner AR; Ravussin E
Diabetologia; 1997 Jul; 40(7):838-42. PubMed ID: 9243106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
